Gladstone’s community continues efforts to support and address the diverse, unique, and complex needs of women in the organization.
News Center
February 24, 2017
Yu Zhang, a postdoctoral scholar at Gladstone, shares how training at Gladstone has benefitted her both professionally and personally.
February 16, 2017
By identifying the role of common cells in connective tissue, Gladstone scientists discovered a new target to fight transmission of the virus.
February 8, 2017
Katherine Pollard, PhD, director of the convergence science initiative at the Gladstone Institutes, has been selected as a Chan Zuckerberg Investigator.
February 8, 2017
A trio of Gladstone scientists are studying the basic biology of the heart to guide the discovery of new therapies for conditions such as congenital heart disease and heart failure.
February 6, 2017
Bay Area philanthropist leaves a legacy as a long-time friend and supporter of the Gladstone Institutes.
February 3, 2017
Bay Area scientists gathered to learn about the latest advances in mass spectrometry.
February 1, 2017
Gladstone scientists are mapping the connections and functions of brain cells to identify new drug targets to treat psychiatric disorders.
January 26, 2017
The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.
January 26, 2017
Thomas Packard, a postdoctoral scholar at Gladstone, talks about his life-long passion for science and how Gladstone's reputation as a top place to do a postdoctoral fellowship led him to the Greene laboratory.
January 17, 2017
Anti-cancer drug prevented less weight gain and caused mice to burn more calories thanks to higher levels of metabolism-boosting brown fat.
January 19, 2017
Gladstone hosted a reception for attendees of the 35th annual J.P. Morgan Healthcare Conference to discuss scientific discoveries, partnering opportunities, and investment strategies involving Gladstone’s research.
January 12, 2017
Scientists discover an enzyme that that could be targeted to treat both Alzheimer’s disease and frontotemporal dementia.
January 12, 2017
Scientists from the Gladstone Institutes will team up with other national experts to better understand frontotemporal dementia.
December 26, 2016
New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson’s, Huntington’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS).
December 19, 2016
Chris Goodfellow shares how his love of motorcycles has influenced his path to Gladstone and fueled his passion for traveling.
December 15, 2016
Research on a gene mutation that causes holes in the hearts of infants revealed insights into how the heart develops and how it stays healthy.
December 12, 2016
Katherine Pollard’s expertise, success, and vision fueled her promotion to director of Gladstone’s Convergence Zone.
December 6, 2016
A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.
December 2, 2016
Anatol Kreitzer was unanimously selected based on his experience training graduate students and his vision for the future.
November 30, 2016
Jennifer Doudna, PhD, was recognized for pioneering technology that transformed gene editing and revolutionized biomedical research.
November 29, 2016
Meredith Calvert shares how her family history and her passions for art and biology led her to a career in microscopy.
November 23, 2016
Yen-Sin Ang, PhD, a research scientist at the Gladstone Institutes, was awarded the Louis N. and Arnold M.
November 21, 2016
In a meeting of the minds, Gladstone hosted a national behavioral neuroscience symposium to share scientific breakthroughs and compare research methods.
November 16, 2016
The delayed antiviral immune response allows the virus to remain undetected in the vagina, which can increase the risk of fetal infection during pregnancy.